Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
about
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityNK cells in the tumor microenvironment.Introduction of shRNAs into human NK-like cell lines with retrovirus.Expression of cDNAs in human Natural Killer cell lines by retroviral transduction.Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityNK cell-based immunotherapy for malignant diseases.Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cellsNatural killer cell engineering for cellular therapy of cancerNK cells: immune cross-talk and therapeutic implications.Present and Future of Allogeneic Natural Killer Cell TherapyGenetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.Role of Natural Killer Cells in HIV-Associated Malignancies.Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapyA new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesNatural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
P2860
Q26773135-CA99AA43-B754-4CB8-8C73-886F3BD72A97Q27692606-9A04F008-2016-4403-885D-5383CB7B642FQ33557537-24A30E57-136E-4E9C-8DFC-CDDEFD390C8FQ33557549-00990F0C-BB3F-4E2C-8213-C69D5955EA98Q33700795-19B5F1F1-E1C4-49EB-9270-C58E6E09DD5FQ33827433-E84BE18D-887E-49B0-B7D4-842992A3E7F6Q34934718-E4053FE1-C31D-4955-8F5D-2D63818BCC27Q35556865-50AF31E8-4C4C-4C75-9A22-502883017312Q35591444-1E243F59-4440-4870-ACDB-92684F8759DBQ35677351-745D4B48-8C68-45E6-A8FD-67FC5806B83BQ35711209-043BDA8B-5D27-4881-9269-664EB72C533AQ35847820-74ACFEE4-807E-45C4-96E5-BBE6FA7EDEC2Q37376346-C84999E6-6947-4927-BA4D-633A57BDEFCBQ37712593-AFD985DD-44BB-424F-B382-11E10837757DQ38019320-592EAFFF-DDC6-46EE-A3A5-EEBE9BF93A60Q38227889-2A61C0CE-7FB4-4CB8-87B0-0D1F9F910E09Q39317127-AA3EA020-60FC-49A0-9B41-52DA1FE69DA8Q41684107-0D49FCF9-7AA0-4B0C-B7D5-0C6F44BB1F57Q53705286-E9139FA0-2BD2-4EE3-ACFE-12F622716CEEQ57300237-A2173FDB-D235-40D2-8627-780D3D3F82FFQ58764532-CC24DB96-738E-4221-A92F-3BFD4E0DBDBD
P2860
Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Stable transduction of the int ...... rization in vitro and in vivo.
@en
type
label
Stable transduction of the int ...... rization in vitro and in vivo.
@en
prefLabel
Stable transduction of the int ...... rization in vitro and in vivo.
@en
P2093
P1433
P1476
Stable transduction of the int ...... erization in vitro and in vivo
@en
P2093
Herberman RB
Mailliard R
Nagashima S
Reichert TE
Whiteside TL
P304
P407
P577
1998-05-01T00:00:00Z